Skip to main content

Animations

MJFF Publications

7076 - 7100 of 8826 Results
Title
Year
  • Year
  • 2017
  • 2019
  • 2022
  • 2017
  • 2022
  • 2024
  • 2024
  • 2020
  • 2020
  • 2020
  • 2016
  • 2020
  • 2024
  • 2020
  • 2015
  • 2015
  • 2016
  • 2018
  • 2018
  • 2019
  • 2020
  • 2020
  • 2021
  • 2016
  • 2020
  • Summary Details
    OPEN
    Title: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awx378
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Cognitive processes that indirectly affect olfactory dysfunction in Parkinson's disease
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.003
    Citation Count: 7
  • Summary Details
    OPEN
    Title: The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100177
    Citation Count: 3
  • Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness
    2017
    Summary Details
    OPEN
    Title: Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness
    Journal Name: Sleep Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.sleep.2017.11.1137
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Hydrop enables droplet-based single-cell ATAC-seq and single-cell RNA-seq using dissolvable hydrogel beads
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.7554/elife.73971
    Citation Count: 68
  • Summary Details
    OPEN
    Title: RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s disease
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/nar/gkae776
    Citation Count: 4
  • Summary Details
    OPEN
    Title: GBA 1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29753
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/acn3.51022
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorder
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/acn3.51269
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/acn3.51164
    Citation Count: 40
  • Summary Details
    OPEN
    Title: α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24664
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25811
    Citation Count: 102
  • Summary Details
    OPEN
    Title: Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26923
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Sex Disparities in Autonomic Symptom Treatment in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12997
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26170
    Citation Count: 303
  • Summary Details
    RESTRICTED
    Title: Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26251
    Citation Count: 115
  • Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
    2016
    Summary Details
    OPEN
    Title: Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26754
    Citation Count: 149
  • Summary Details
    OPEN
    Title: Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27361
    Citation Count: 203
  • 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's disease
    2018
    Summary Details
    RESTRICTED
    Title: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27451
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27806
    Citation Count: 139
  • Summary Details
    OPEN
    Title: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27989
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28206
    Citation Count: 194
  • Summary Details
    OPEN
    Title: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28608
    Citation Count: 39
  • Summary Details
    OPEN
    Title: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2
    Citation Count: 216
  • Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)
    2020
    Summary Details
    RESTRICTED
    Title: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.